Clinical trial
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
NCT03249259 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 10, 2016
- Completion date
- September 30, 2019
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.